CBD basics
What is CBG and how does it differ from CBD?
Written by: Author pendingReviewed by: Reviewer pendingUpdated:
CBG (cannabigerol) is a minor, non-intoxicating cannabinoid. Its acid form, CBGA, is the precursor the plant uses to build other cannabinoids, so mature hemp holds CBG in much smaller amounts than CBD (Int J Mol Sci, 2022). Pharmacologically it binds cannabinoid receptors with activity between THC and CBD, with far fewer human studies behind it.
CBG gets called the "mother cannabinoid," and for once the nickname is chemically accurate. It is also one of the least-studied cannabinoids sold at retail, and both facts matter when reading a CBG label.
Why is CBG called the precursor cannabinoid?
Cannabis builds its cannabinoids from a common starting point. The plant first makes cannabigerolic acid (CBGA), then enzymes convert CBGA into the acid forms of THC, CBD and CBC. A 2022 review in the International Journal of Molecular Sciences describes CBGA as the precursor to various phytocannabinoids, with CBG itself produced when CBGA loses a carboxyl group through heat. Because most CBGA has already been converted by harvest, the review notes CBG is "present in much smaller quantities" than CBD in the mature plant.
That is why CBG was historically expensive. Getting meaningful CBG from hemp means either harvesting early, before conversion, or growing cultivars bred to stall the enzymes that consume CBGA. Modern CBG-dominant hemp strains do the latter, which is what made CBG isolates and gummies commercially viable.
How does CBG act differently from CBD?
A 2021 review in the Journal of Pharmacology and Experimental Therapeutics lays out the pharmacology. CBG binds the cannabinoid receptors with affinity and activity between THC and CBD, and it has interactions CBD does not: the review highlights activity at alpha-2 adrenoceptors and 5-HT1A receptors. Like CBD, it is not intoxicating.
The same review is blunt about the state of the evidence, describing CBG as an unregulated and sparsely studied supplement with potential toxicological hazards that have not been characterized. Most of what is known comes from cell and animal work. Human pharmacokinetic and safety data for CBG are thin compared with the dozens of human CBD studies NCCIH and others can point to; NCCIH's consumer page does not single out CBG at all among the more than 100 cannabinoids it mentions.
Is CBG legal the same way CBD is?
Yes. Federal law defines hemp to include "all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers" from a plant at or under 0.3 percent delta-9 THC by dry weight. CBG and CBGA extracted from compliant hemp are hemp. The amended definition taking effect in late 2026 adds a total THC standard and a 0.4 mg per-container THC cap, and it excludes cannabinoids the plant cannot naturally produce. CBG is a natural plant cannabinoid, so that exclusion does not reach it; the THC cap applies to the whole product regardless of which cannabinoid is on the front label.
What does a CBG label need to show?
The same things a CBD label does, with one extra line. The certificate of analysis should list CBG and CBGA separately, because many "CBG" tinctures are actually a mix of the two. A canine pharmacokinetic study in Frontiers in Veterinary Science illustrates how much acid forms can matter: the oils tested contained about 0.7 mg/mL of CBGA alongside the CBD and CBDA, and the acid forms of cannabinoids reached blood levels 2- to 3-fold higher than the neutral forms. A label that says "30 mg CBG" without a COA breakdown is leaving the most useful number off.
This page is general information, not personalized guidance.
General information, not personalized guidance.
Sources
- The Origin and Biomedical Relevance of Cannabigerol International Journal of Molecular Sciences, via PubMed (accessed 2026-10-13)
- The Pharmacological Case for Cannabigerol Journal of Pharmacology and Experimental Therapeutics, via PubMed (accessed 2026-10-13)
- 7 U.S. Code 1639o - Definitions Cornell Law School, Legal Information Institute (accessed 2026-10-13)
- Cannabis (Marijuana) and Cannabinoids: What You Need To Know NCCIH, National Institutes of Health (accessed 2026-10-13)
- Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, delta-9-THC, THCA and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract Frontiers in Veterinary Science (accessed 2026-10-13)
Related questions
What is CBD and how is it made from hemp?
CBD (cannabidiol) is one of more than 100 cannabinoids in Cannabis sativa, and it does not produce intoxication the way THC does. Hemp is cannabis with no more than 0.3 percent...
What is CBN and how is it made?
CBN (cannabinol) is a minor cannabinoid that forms when THC breaks down with heat, air and time; Montana's cannabis regulator calls it a degradation product of delta-9 THC found...
What is the entourage effect, and how strong is the evidence?
The entourage effect is the proposal that cannabinoids and terpenes act differently together than alone. Russo's 2011 review in the British Journal of Pharmacology popularized...
What are CBDA and CBGA in dog tinctures?
CBDA and CBGA are the raw acid forms of CBD and CBG, the molecules as the hemp plant makes them before heat converts them. They matter in dog products because a canine...